|07:00 03-Aug-2012||GSK||GSK completes the acquisition of HGS||RNS||+1.31%|
|17:12 02-Aug-2012||GSK||Transaction in Own Shares||RNS||+2.20%|
|17:07 01-Aug-2012||GSK||Transaction in Own Shares||RNS||+2.83%|
|11:47 01-Aug-2012||GSK||Total Voting Rights||RNS||+2.83%|
|17:00 31-Jul-2012||GSK||Transaction in Own Shares||RNS||+3.41%|
|17:09 30-Jul-2012||GSK||Transaction in Own Shares||RNS||+3.21%|
|13:30 30-Jul-2012||GSK||GSK announces initial tender offer results for HGS||RNS||+3.21%|
|17:19 27-Jul-2012||GSK||Transaction in Own Shares||RNS||+2.70%|
|12:42 27-Jul-2012||GSK||Director/PDMR Shareholding||RNS||+2.70%|
|17:00 26-Jul-2012||GSK||Transaction in Own Shares||RNS||+1.49%|
|12:00 25-Jul-2012||GSK||Half Yearly Report||RNS||+0.05%|
|17:13 23-Jul-2012||GSK||Director/PDMR Shareholding||RNS||-1.76%|
|16:10 19-Jul-2012||GSK||Director/PDMR Shareholding||RNS||-0.85%|
|18:26 17-Jul-2012||GSK||Director/PDMR Shareholding||RNS||+1.30%|
|15:38 17-Jul-2012||GSK||Director/PDMR Shareholding||RNS||+1.30%|
|14:15 16-Jul-2012||GSK||GSK to acquire HGS for $14.25 per share in cash||RNS||+1.25%|
|17:53 12-Jul-2012||GSK||Director/PDMR Shareholding||RNS||-0.54%|
|17:51 12-Jul-2012||GSK||Director/PDMR Shareholding||RNS||-0.54%|
|17:47 12-Jul-2012||GSK||Director/PDMR Shareholding||RNS||-0.54%|
|16:00 11-Jul-2012||GSK||GSK announces positive data from Harmony 8 study||RNS||-1.86%|
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
You will be redirected in five seconds